SURGEPAYS, INC. (SURG)

Every figure this model derived for SURG, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 18,590 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 12,022,741 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 4,858,095 AssetsCurrent 2026-06-30
current liabilities 26,161,011 LiabilitiesCurrent 2026-06-30
equity -20,693,903 StockholdersEquity 2026-06-30
interest expense 3,580,331 InterestExpenseNonoperating 2026-06-30
ocf -15,391,765 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 67,056,128 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 1,701,735 ShareBasedCompensation 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up SURG on one particular measure came for.

RatioValue
cash operating margin-38.3
current ratio0.19
current ratio reported0.19
deferred revenue growth-91.77
dilution pct5.06
fcf margin-22.98
growth cv3.92
interest cover-7.68
operating margin-41.0
owner earnings margin-25.52
revenue growth83.91
revenue growth per share75.06
roic-510.13
rule of 4042.91
sbc pct revenue2.54

What to be careful about

What this model itself distrusts about SURG's figures. Written by the derivation as it ran, not added afterwards.